cle de peau BEAUTE RADIANT FOUNDATION N B40
NDC 58411-635, octinoxate and titanium dioxide, emulsion, from SHISEIDO AMERICAS CORPORATION.
- Product NDC
- 58411-635
- Status
- Listed
- Labeler
- SHISEIDO AMERICAS CORPORATION
- Dosage form
- EMULSION
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58411-635 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTINOXATE1.07 g/21mL
- TITANIUM DIOXIDE.3 g/21mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58411-635-60 | 58411063560 | 1 TUBE in 1 CARTON (58411-635-60) / 21 mL in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58411-635 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58411-635 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58411-635. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.